AbbVie (ABBV) Revenue (2012 - 2026)
AbbVie (ABBV) posted quarterly Revenue of $15.0 billion for Q1 2026, up 12.43% year-over-year from $13.3 billion in Q1 2025, and down 9.72% quarter-over-quarter from $16.6 billion in Q4 2025.
AbbVie (ABBV) Revenue (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Revenue for 15 consecutive years, with $15.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 12.43% year-over-year to $15.0 billion; the TTM figure through Mar 2026 stood at $62.8 billion (up 9.5% YoY), while the FY2025 annual figure was $61.2 billion, up 8.57% from the prior year.
- Revenue fell to $15.0 billion in Q1 2026 per ABBV's latest filing, from $16.6 billion in the prior quarter.
- Across five years, Revenue topped out at $16.6 billion in Q4 2025 and bottomed at $12.2 billion in Q1 2023.
- Historically, Revenue has averaged $14.4 billion across 5 years, with a median of $14.5 billion in 2024.
- Annual changes were most pronounced in 2023 — Revenue fell 9.7% — and 2026, when it gained 12.43%.
- AbbVie's Revenue stood at $15.1 billion in 2022, then dropped by 5.42% to $14.3 billion in 2023, then grew by 5.6% to $15.1 billion in 2024, then gained by 10.04% to $16.6 billion in 2025, then retreated by 9.72% to $15.0 billion in 2026.
- Business Quant data shows ABBV's Revenue at $15.0 billion in Q1 2026, $16.6 billion in Q4 2025, and $15.8 billion in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|